Grimes & Company Inc. lessened its stake in MetLife, Inc. (NYSE:MET – Free Report) by 8.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,743 shares of the financial services provider’s stock after selling 971 shares during the period. Grimes & Company Inc.’s holdings in MetLife were worth $886,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the period. GoalVest Advisory LLC grew its position in shares of MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 165 shares during the period. Bank & Trust Co bought a new stake in shares of MetLife during the 2nd quarter valued at $39,000. Crewe Advisors LLC grew its position in shares of MetLife by 602.5% during the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 482 shares during the period. Finally, Larson Financial Group LLC grew its position in shares of MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 239 shares during the period. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Up 0.3 %
Shares of MET stock opened at $84.36 on Friday. The stock has a market cap of $59.99 billion, a P/E ratio of 28.99, a PEG ratio of 0.69 and a beta of 1.04. MetLife, Inc. has a 52 week low of $57.91 and a 52 week high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The company’s fifty day simple moving average is $79.37 and its two-hundred day simple moving average is $74.36.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be issued a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.58%. MetLife’s dividend payout ratio (DPR) is presently 74.91%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on MET shares. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a research report on Monday, July 8th. Bank of America cut their price objective on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Morgan Stanley lowered their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, Wells Fargo & Company lifted their target price on shares of MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $88.46.
Read Our Latest Stock Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Compound Interest and Why It Matters When Investing
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is a Bond Market Holiday? How to Invest and Trade
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Consumer Staples Stocks, Explained
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.